Peter Hotez has warned that dengue and Zika pandemics could become the "new normal" due to climate change. Dr Randall Bock asks why the 'experts' are still trying to scare us with non-scary viruses and unlikely scenarios.
The post The ‘Experts’ Are Still Trying to Scare Us With Non-Scary Viruses appeared first on The Daily Sceptic.
Now you know why outbreaks still regularly occur in highly vaccinated populations
Informed with Aaron Siri | September 24, 2026
On the topic of splitting up the MMR vaccine into 3 separate vaccines, everyone should know that in 2012, two Merck virologists came forward and explained that when Merck sought to change the label on its MMR vaccine and approval for ProQuad (a combination MMR and varicella vaccine), it “falsely certified as having an efficacy rate that is significantly higher than it actually is.” (See Complaint ¶ 1.)
As detailed in the whistleblower lawsuit, Merck obtained a license for its mumps vaccine in 1967. (Comp. ¶ 16.) In the late 1990s, to obtain approval for ProQuad and change the label on its MMR vaccine, Merck needed to reconfirm its claims of efficacy for its mumps vaccine made thirty years prior. (Comp. ¶ 22.) Two of Merck’s virologists working on testing the efficacy of the mumps vaccine revealed that after Merck could not demonstrate a 95% efficacy for its mumps vaccine, the results were simply fraudulently falsified to achieve this result. (Comp. ¶¶ 15-131.)
As explained by the virologists, Merck took blood samples pre-vaccinated with the mumps vaccine and then exposed them to the mumps virus. (Comp. ¶¶ 25-28.) Suspecting a test against a live strain of mumps would not yield a 95% efficacy, Merck tried to improperly obtain this rate using an attenuated strain of the mumps virus. (Comp. ¶¶ 29-30.) When that would not achieve 95% efficacy, Merck tried different virus dilutions, different staining procedures, and even more liberal counting techniques. (Comp. ¶¶ 31-32.) The Merck lab even improperly added animal antibodies to the blood samples and still could not achieve a 95% efficacy rate. (Comp. ¶¶ 33-39.)
When it was clear that even improper testing techniques could not produce the desired result, the test reports were simply falsified. (Comp. ¶¶ 40-51.) According to the Merck virologists, to document the desired efficacy rate, Merck destroyed result sheets and falsified various documents. (Id.) The Merck virologists claim this fraud was done with the direct authority and approval of Merck’s senior management. (Comp. ¶¶ 52-58.)
Now you know.
This may explain why outbreaks of mumps still regularly occur in highly vaccinated populations. See, e.g.:
The HighWire with Del Bigtree | September 24, 2026
Fresh off testifying at Canada’s Allison Inquiry, physicist Denis Rancourt joins Del to examine mortality and cancer data among 5- to 24-year-olds—and what could be behind their striking, lockstep rise.
Introduction by Fabio Giuseppe Carlo Carisio
Originally published on October, 6, 2025 – updated with VIDEO on August, 24, 2026
Excerpt from American Thinker interview to American Epidemiologist Nicolas Hulscher
«The oncogenic potential of SARS-CoV-2 has been hypothetically proposed, but real-world data on COVID-19 infection and vaccination are insufficient. Therefore, this large-scale population-based retrospective study in Seoul, South Korea, aimed to estimate the cumulative incidences and subsequent risks of overall cancers 1 year after COVID-19 vaccination. Data from 8,407,849 individuals between 2021 and 2023 were obtained from the Korean National Health Insurance database».
We can read in the Abstract of the Korean study Kim et al. titled “1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea” which was conducted by Hong Jin Kim (Department of Orthopedic Surgery, Kyung-in Regional Military Manpower Administration, Suwon) Min-Ho Kim (Informatization Department, Ewha Womans University Seoul Hospital, Seoul), Myeong Geun Choi and Eun Mi Chun (both in Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, 1071, Anyangcheon-ro, Yangcheon-gu, Seoul).
The research was published on BMC Biomarker Research 13 (part of Springer Nature).
«The participants were categorized into two groups based on their COVID-19 vaccination status. The risks for overall cancer were assessed using multivariable Cox proportional hazards models, and data were expressed as hazard ratios (HRs) and 95% confidence intervals (CIs). The HRs of thyroid (HR, 1.351; 95% CI, 1.206–1.514), gastric (HR, 1.335; 95% CI, 1.130–1.576), colorectal (HR, 1.283; 95% CI, 1.122–1.468), lung (HR, 1.533; 95% CI, 1.254–1.874), breast (HR, 1.197; 95% CI, 1.069–1.340), and prostate (HR, 1.687; 95% CI, 1.348–2.111) cancers significantly increased at 1 year post-vaccination» adds the Abstract.
«In terms of vaccine type, cDNA vaccines were associated with the increased risks of thyroid, gastric, colorectal, lung, and prostate cancers; mRNA vaccines were linked to the increased risks of thyroid, colorectal, lung, and breast cancers; and heterologous vaccination was related to the increased risks of thyroid and breast cancers. Given the observed associations between COVID-19 vaccination and cancer incidence by age, sex, and vaccine type, further research is needed to determine whether specific vaccination strategies may be optimal for populations in need of COVID-19 vaccination».
The Korean study indirectly confirms the warning raised by two Chinese universities in October 2020, even before the Covid-19 vaccines were released, regarding the very serious risks of lung disease that both mRNA and mDNA gene sera could cause.
Furthermore, the study found that booster doses were associated with significantly higher risks of gastric and pancreatic cancer. For pancreatic cancer, the risk more than doubled in booster recipients.
These statistics confirmed the validity of the warning raised by the late virologist Luc Montagnier and British oncologist Angus Dalgleish.
More details below inside the analysis of American epidemiologist Nicolas Hulscher.
Fabio Giuseppe Carlo Carisio – Gospa News director
Originally published by Nicolas Hulscher, MPH on Substack Focal Points – Courageous Discourse by McCullough Foundation
About a month ago, the first-ever population cohort study reported increased cancer risks following COVID-19 vaccination. In Italy, nearly 300,000 residents were tracked for 30 months, showing that mRNA shots significantly increased the risk of overall cancer, breast cancer, bladder cancer, and colorectal cancer
Now, a second—and far larger—population-based cohort study by Kim et al from South Korea has corroborated and expanded upon those findings. Drawing on a massive sample of more than 8.4 million people, this is one of the most powerful cancer-safety datasets ever analyzed.
The results are striking. After accounting for age, sex, comorbidities, income level, and prior COVID-19 infection, COVID-19 vaccination was linked to significant increases in multiple major cancers, with the signal consistent across all vaccine platforms, both sexes, and age groups:
Interpretation: An HR of 1.53 for lung cancer means that vaccinated individuals developed lung cancer at a rate 53% higher than matched unvaccinated peers, over the same one-year follow-up period. Similar interpretations apply to each cancer type.
AstraZeneca Taken to British Court for as many as 80 Damages Claims on “Defective” Covid Jab
Interpretation: The elevated cancer risks were not confined to one vaccine platform. Whether adenoviral-vector (cDNA), mRNA, or mixed schedules, each vaccine type was associated with a measurable increase in overall cancer — and each had specific cancer sites driving the signal. In other words, no vaccine technology was free of cancer risk in this dataset.
Interpretation: Booster doses were associated with notably higher risks of gastric and pancreatic cancers. For pancreatic cancer, the risk more than doubled in boosted individuals.
New Study Finds Covid-Vaccinated Kids Face ELEVATED CANCER RISK, Immune System Damage
Interpretation: Both the overall and site-specific results show a consistent pattern — every demographic group experienced elevated cancer risks, though the type and absolute burden varied. Women and the elderly were hit hardest, but no population segment was spared.
Taken together, the evidence is now impossible to ignore. The only two population-level cohort studies ever conducted on COVID-19 vaccination and cancer — one in Italy and one in South Korea — have both found major increases in cancer risk.
The Italian study (≈300,000 people, 30-month follow-up) identified significant elevations in overall cancer, breast, bladder, and colorectal cancers. The South Korean study (8.4 million people, 1-year follow-up) confirmed and expanded these findings, documenting increased risks of overall cancer plus six site-specific cancers (lung, prostate, thyroid, gastric, colorectal, and breast).
Critically, the signal was observed across all vaccine types — both mRNA and viral-vector (cDNA) shots — and in every demographic group analyzed. In plain terms: both major COVID-19 vaccine platforms appear to be carcinogenic
With two independent national datasets converging on the same conclusion, governments, regulators, clinicians, and researchers must confront a sobering reality: nearly 70% of the global population has been injected with a carcinogenic product. The evidence demands immediate market withdrawal of these products.
17 Ways mRNA Shots May CAUSE CANCER, According to Over 100 STUDIES
At the McCullough Foundation, we are deeply investigating both the molecular mechanisms and the population-level data linking COVID-19 vaccination to cancer. We are currently preparing several new studies to expand this critical line of evidence.
This work requires substantial time, expertise, and resources, and we ask for your support in funding this urgent research: mcculloughfnd.org/products/donate-1
Oririnally published by Nicolas Hulscher, MPH on Substack Focal Points – Courageous Discourse by McCullough Foundation
Nicolas Hulscher, MPH – Epidemiologist and Foundation Administrator, McCullough Foundation
MAIN SOURCES
FOCAL POINTS – COURAGEOUS DISCOURSE
GOSPA NEWS – TURBO-CANCER AND VACCINES DOSSIER
RELATED TOPICS
Login